AI and stratifying risk in NCD Management

  • 00Days
  • 00Hours
  • 00Minutes
  • 00Seconds

About the Case Presentation

Artificial Intelligence (AI) is revolutionizing the management of non-communicable diseases (NCDs) by enabling more accurate and timely risk stratification. Through advanced data analytics, AI can analyze vast amounts of patient data—such as medical history, genetic information, and lifestyle factors—to predict individual risk profiles for diseases like cardiovascular conditions, diabetes, and cancer. By identifying high-risk patients early, AI helps in personalizing treatment plans, optimizing resource allocation, and improving clinical outcomes. As AI models evolve, they have the potential to significantly enhance preventive care, enabling healthcare providers to intervene proactively and reduce the burden of NCDs globally.

About the Speaker

Ananth Subramanian

Ananth Subramanian

Global CEO & Vice Chairman, Trustr.ai, California, U.S

About the Speaker

Martha Murphy

Marta Murphy

Global COO, APAC Ceo, Truste.ai, California, U.S